A systematic review with meta-analysis was carried out to investigate the effects of increased nutritional intake, via either macronutrient or multi-nutrient intervention, during the neonatal period on neurodevelopmental outcomes in infants born at <32 weeks of gestation or weighing <1501g at birth.
• There is a lack of recent adequately powered studies on this topic
• Additional research is required and should focus on using standardised nutritional interventions and an agreed neurodevelopmental assessment battery, as the lack of homogeneity was a major limitation in this review Adverse neurodevelopmental outcome is common in very preterm (VP) and very low birth weight (VLBW) infants(1, 2). Postnatal growth failure is also common in these infants (3) .
Epidemiological studies (4, 5) have shown that infants born extremely preterm are often lighter and have a smaller head circumference compared with published population norms at expected delivery date, despite being born with average weight and head circumference for their gestation. Neurodevelopmental outcomes of preterm infants are subject to multiple influences and it is likely that nutrition plays a key part. Furthermore, nutrition can be measured and modified, and so offers a potential intervention to improve outcomes. At the same time, it should be acknowledged that altering early nutrition in preterm infants could potentially result in changes to body composition and in turn the risk of obesity and noncommunicable disease in later life (6) . Although there is evidence that in VLBW infants poor growth during the early postnatal period is associated with a higher incidence of neurodevelopmental impairment at toddler age (7) , the findings of studies that have investigated the effect of early and/or increased nutrition in preterm infants have been inconsistent (8) (9) (10) , and the evidence for nutritional interventions to improve neurodevelopmental outcome is unclear. We therefore carried out a systematic review to
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examine the effects of increased early nutritional intake on neurodevelopmental outcomes in infants born VP and/or with VLBW assessed at toddler age or during childhood.
METHOD Study design
Studies were considered if they were randomised controlled trials (RCT), non-randomised control trials (NRCT), or observational studies. There were no restrictions on publication status, language, or year of publication.
Inclusion criteria
Studies that specifically compared an intervention providing increased nutrient intakes during the neonatal period (defined as first 28 days after birth) in infants born VP, <32 weeks of gestational age (GA), or with birth weight (BW) <1501g, with a control group receiving a 'standard' amount of nutrition, were eligible for inclusion. The intervention had to include higher quantity of nutrients over a defined period, such as consistently higher nutrient intakes in the intervention group compared to the control group, a difference in the increment of nutrient increase during the intervention period, or a difference in the length of intervention to provide a higher amount of nutrition overall. Nutritional interventions could be parenteral nutrition (PN), enteral nutrition (EN), or a combination of both. Studies were excluded if there was no documented protocol to increase nutrient intake, or if they focused on one single specific micronutrient.
Outcome measures
Outcome measures included neurodevelopmental outcome at 12-18 months, 24 months of corrected gestational age (CGA) (these ages of assessment hereafter referred to as toddler age) and/or at childhood as well as neurological status (presence or absence of Cerebral Palsy, CP). Since the Mental Developmental Index (MDI) and Psychomotor Developmental
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Index (PDI) subscales of the Bayley Scales of Infant Development Second edition (11) (BSIDII) are widely used, meta-analyses were based on these subscales. Studies that reported cognitive, language and motor subscales of Bayley Scales of Infant and Toddler Development Third edition(12) (Bayley III), were converted into MDI and PDI using Moore et al's method (13) to allow meta-analyses.
Searches and information source
A search was carried out by using the search strategy detailed in table 1. The electronic databases MEDLINE, EMBASE and CINAHL were searched, with the last search carried out on 15th Jan 2015. Conference abstracts and other citations were identified using Web of Science. Reference searching was performed on articles that were selected for review.
Study selection
Studies were assessed for eligibility by two reviewers (SC and MJ) independently. Selection was on the basis of titles and abstracts where possible, with the full text obtained where necessary.
Data collection process
Data on study characteristics, nutritional interventions, nutritional intakes, and outcome measures (neurodevelopmental outcomes, morbidity and mortality) were collected using a study specific spreadsheet. Additional data were obtained from authors where required.
Risk of bias assessment
The quality of RCT and NRCT was assessed using the Cochrane Risk of Bias Assessment Tool (14) , and observational studies were assessed using the Newcastle Ottawa Scale (15) .
Synthesis of results
Parenteral nutrition and EN studies were analysed separately due to their relative timing of use during the neonatal period. Meta-analyses were performed where appropriate. Analysis was carried out using the software Review Manager v5.2(16). Heterogeneity was checked
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This article is protected by copyright. All rights reserved. (17) . When means and standard deviations (SD) were not provided, they were calculated using the method described by Hozo et al (18) . Meta-regression was carried out using Stata version 12.1 (StataCorp LP). All statistical analyses were conducted by authors SC and MJ.
RESULTS

Study selection
The review process is demonstrated in figure 1 . Interventions varied between studies; five of the six PN trials investigated early delivery and increased content of protein (19) (20) (21) (22) (23) , the remaining PN trial investigated increases in both micro-and macronutrients (24) . Four of the seven EN studies investigated multi-nutrient supplementation to either maternal or donor breast milk (8) (9) (10) (25) (26) (27) (28) , two studies investigated protein supplementation to breast milk (29, 30) , and one study compared protein enriched formula to standard formula (31) . In addition to supplementation, Lucas et al also conducted trials that compared multi-nutrient enriched sole diet, containing preterm formula only, to either only donor breast milk (9) or only term formula (10) , these intervention hereafter is referred to sole diet trials. In the two studies that investigated increasing both PN and EN,
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Primary outcomes
Neurodevelopmental outcome
Neurodevelopmental outcomes were reported in all included studies. Mental Developmental Index and PDI were reported in ten studies (8, 10, 19-21, 23, 26, 28, 30, 32) . Knobloch et al's
Developmental Inventory Quotients(33) were further reported in two studies (8, 9) . Two studies reported subscales of Bayley III(24, 34). Cormack et al (24) reported scores on cognitive, language, and motor subscales which were also converted into MDI and PDI, and (22) , and the Griffiths Mental Development Scales(36) (GMDS) used by Biasini et al (29) .
Studies that investigated neurodevelopmental outcome in childhood and adolescence reported Verbal (VIQ) and Performance (PIQ) Intelligence Quotients, and Full Scale
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Neurodevelopmental outcome at age 12-18 months: Results of meta-analysis
Meta-analysis of EN trials (8, 10, 26, 28, 30) , PN trials (19) (20) (21) 24) and two sole diet trials (10, 28) showed non-significant effects on MDI and PDI. A negative mean difference was observed in the meta-analysis of PN studies and MDI (figure 2), and although this was not statistically significant, this finding is consistent with meta-analysis at 24 months (figure 5).
Significant heterogeneity was found in PDI in the meta-analysis of EN trials (I 2 = 95%, p<0.001) and sole diet trials (I 2 = 90%, p<0.001), demonstrated in figure 3 and figure 4, respectively.
Neurodevelopmental outcome at age 12-18 months: Results of meta-regression
The relationship between early increased nutrition and neurodevelopmental outcome was further explored using meta-regression. Energy and protein were considered separately. suggests that for every extra calorie per kg per day of enteral energy intake, there may be a 0.75 point increase in PDI.
Neurodevelopmental outcome at age 24 months: Results of meta-analysis
Three PN studies (19, 23, 34) reported neurodevelopmental outcomes at 24 months; only two were appropriate for meta-analysis. The remaining study, Burattini et al (34) , reported
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Neurodevelopmental outcome: Results not included in meta-analysis
Tan et al (32) and Rochow et al (22) investigated increasing both EN and PN, and neither study reported significant effects on neurodevelopment at 3 and 9 months, or at 24 months, respectively.
Similarly, Burattini et al (34) found no significant differences in Bayley III scores at 24 months between infants who received increased amino acid intake and those who received standard amount from birth to day four.
Two EN studies that investigated increasing protein showed contrasting results(29, 31), Svenningsen et al (31) reported no group differences in neurodevelopmental outcomes at two years of age, whereas Basini et al (29) found that infants receiving additional protein performed better in the items of the GMDS at three months CGA (95.5 vs 109.8, p = 0.04).
Long term cognitive outcomes were reported by two follow-up studies from the same original cohort. Lucas et al (27) reported no significant differences in the VIQ, PIQ and FSIQ at 7.5-8
years of age between the intervention and control groups in both the sole diet trial and the supplementation trial. In contrast, Isaac et al (25) found that the mean±SD VIQ at the median age of 16 years was significantly higher in the intervention group compared to the control group from the same cohort (102±14 vs 94±11, p < 0.01).
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Rate of survival without neurodevelopmental impairment:
Meta-analyses of the rate of survival without neurodevelopmental impairment were carried out on four EN (9, 10, 26, 34, 41) figure 6 . Of note, one RCT(10) reported the incidence of MDI < 70 and PDI < 70 seperately, rather than the number of infants with neurodevelopmental impairment (defined as either MDI or PDI being less than 70). Therefore, in order to be included in the meta-analysis, the total number of infants with either MDI < 70 and PDI < 70 were combined to give a total number of infants with impairment, though the actual number of infants with neurodevelopmental impairment may be overestimated in comparison to the other included studies, as some infants with both a MDI < 70 and PDI < 70 will have been double counted.
Secondary outcomes
Neurological outcome
Four RCTs and two observational studies reported the rate of CP. Meta-analyses of two EN trials (27, 28) , four PN trials (19) (20) (21) 23) , and two sole diet trials (12, 28) 
Rate of neurodevelopmental impairment at toddler age: Results of meta-analysis
Definitions of neurodevelopmental impairment differed across studies. Meta-analysis of three PN trials (20, 21, 23 ) (which defined impairment as at least one of the following: MDI or PDI <70, presence of CP, hearing loss or blindness) showed no significant differences in the
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rates of neurodevelopmental impairment at 18-24 months with an OR of 1.10 (0.78, 1.56; p= 0.58).
Rate of neurodevelopmental impairment: Results not included in meta-analysis
Of the remaining studies that reported neurodevelopmental impairment (9, 10, 26, 27, 29) , only one RCT, Lucas et al 1990 (10) , and its follow-up(27), reported a significantly higher incidence in the group that received standard nutrition, with a significantly lower incidence of psychomotor impairment (defined as PDI < 86) in the group that received increased nutrition at 18 months. The follow-up study also reported a significantly lower rate of cognitive impairment (VIQ < 85) at 7.5-8 years in a combined cohort of infants that received either increased EN via sole diet or supplementation. This remained statistically significant after adjusting for CP (27) .
DISCUSSION
This review found that increased PN, particularly increased amino acid intake in the early period after birth, may result in sub-optimal neurodevelopmental outcomes at 24 months CGA. However, only two studies could be pooled in the meta-analysis (figure 5) due to the variation in outcomes measures and data reporting, therefore this finding requires confirmation through further research. On the other hand, importantly, the review also suggests that increased enteral nutrition may result in increased numbers of very preterm and/or very low birthweight infants surviving without neurodevelopmental impairment. A speculative explanation for such findings is that the omission of infants who did not survive for neurodevelopmental assessment and were thus omitted from the meta-analyses, may have confounded the results. By including survival in the outcome as 'survival without neurodevelopmental impairment', we were able to adjust for this possible confounding effect, and have shown that higher PN intake does not increase the likelihood of neurodevelopmental impairment in preterm infants. With regard to the negative outcome
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from early increased amino acid intake seen in Blanco et al's study, it is important to consider that this could be related to the specific composition of the amino acid solution, rather than to overall intake of protein. Therefore, findings from this study may not be generalisable to other studies with early increased amino acid interventions. Additionally, this study has a high attrition rate with the fewest participants (n = 16) in the meta-analysis at 24 months. Overall, our review showed no significant effects from increased nutrition on the rates of CP. 
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Significant heterogeneity was found across the meta-analyses. The meta-analysis for PN trials and MDI at 12-18 months showed significant heterogeneity (I 2 = 75.9%) between the study designs. The only RCT that was pooled into this meta-analysis demonstrated significant negative findings within the subgroup analysis, however, this study included the smallest sample size and when combined with observational studies, the mean difference became statistically non-significant. Similarly, meta-analysis of EN studies and PDI at 12-18 months CGA showed I 2 = 95%, where significant benefits were described by two of the five studies, with Lucas et al (10) reporting the greatest effect. Although this study (10) was assessed to contain low risk of bias, it was conducted more than two decades ago, and further studies in a more contemporary sample may strengthen the evidence for the conclusion made in this study. Likewise, the reviewed literature is dominated by research published over a decade ago, and there is a lack of recent adequately powered studies on
this topic. Recent trials that were included were predominately single centered. Results of larger multi-centered studies investigating neurodevelopmental outcome as a primary or secondary outcome are not currently available.
A considerable amount of variation in the type of interventions, outcomes, and age at assessment was found across the studies, particularly in the EN trials. The components of nutritional interventions differed markedly between studies. The proportion of mother's breast milk and supplementation used in individual trials was also not controlled except in one of the supplement trials (9) . Consequently, the actual effect of increased nutrition might not be fully reflected in these studies. Another major limitation in the data is that not all the studies reported whether the actual nutritional intervention was achieved, and for the 11 studies that have reported this, only 4 studies achieved the intended nutrient intakes.
While this review supports the concept that early nutrition is important for optimal neurodevelopment, it provides no clarity on which specific nutrients or clusters of nutrients might be beneficial -or potentially harmful. Furthermore, the recommended nutritional intakes for preterm infants have changed over the last two decades, and this is demonstrated by the significant variations between the nutrition interventions in studies published at different times over the past 20 years or so (see table S1 ). The older studies appear to provide smaller amounts of nutrition in their control groups compared to more recent studies. When the standard nutrition is below optimal, providing more nutrition may be beneficial; however, providing nutrition above the optimal level may not be beneficial and may even be harmful.
Nutrition is complex and it is likely that there is a pattern of optimal intake of multiple nutrients, including energy, amino acids and micro-nutrients, which must be balanced with metabolic capacity. Including neurodevelopment as an outcome measure to identify these intakes is vitally important. In addition to nutrition, other contributing factors such as
intrauterine toxins and infections, maternal co-morbidities, genetic factors and many other variables could not be considered in this review.
CONCLUSION
This study provides a comprehensive review of the published evidence for the effects of increased early nutrition, either via increased macronutrients or multi-nutritional intervention, on neurodevelopmental outcome in VP and/or VLBW infants at toddler age and in childhood.
The review has shown that increased early nutrition may increase the likelihood of survival without neurodevelopmental impairment in VP and/or VLBW infants, but the direct relationship between neurodevelopmental outcome and nutrition after birth remains unclear.
Whilst early nutritional interventions may be beneficial for neurodevelopment, optimal nutritional regimens are still not defined, and as such there is a need for additional research in this field. Further research should follow the Core Outcome Measures in Effectiveness Trials initiative (43) to develop a core set of agreed standardised outcomes. This will facilitate data synthesis for future systematic reviews, as the lack of homogeneity was a major limitation in this review. 
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